# Clinical Trial of Doxycycline VS BPG for Early Syphilis (SY-DOXY)

> **NCT04838717** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 200 (actual)

## Conditions studied

- Syphilis

## Interventions

- **DRUG:** BPG
- **DRUG:** Doxycycline

## Key facts

- **NCT ID:** NCT04838717
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-06
- **Primary completion:** 2025-07-23
- **Final completion:** 2025-07-23
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04838717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04838717, "Clinical Trial of Doxycycline VS BPG for Early Syphilis (SY-DOXY)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04838717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
